Suchergebnisse - "Saxena, Ashish"

PubPharm (2)

1

Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer : survival outcomes and molecular correlates of a randomized phase II trial

enthalten in: Nature communications | 2023

von Altorki, N. | Walsh, Z. | Melms, J. | +19

ErratumIn: Nat Commun. 2024 Jan 3;15(1):225. - PMID 38172131

2

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer : a single-centre, randomised phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Altorki, N. | McGraw, T. | Borczuk, A. | +16

CommentIn: Lancet Oncol. 2021 Jun;22(6):744-746. - PMID 34015310

1
[1]